OBJECTIVE: To test the feasibility of introducing oral rabies vaccine (vaccinia recombinant rabies glycoprotein) to improve domestic dog immunisation coverage in a selected area. DESIGN: A prospective field trial. SETTING: Panadura, an area relatively isolated by waterways, making it a suitable field laboratory. METHODS: A routine parenteral vaccination program was carried out. A house to house survey identified the residual non-vaccinated dogs in the selected area. Oral vaccine was offered to the non-vaccinated domestic dogs. RESULTS: Of 4322 dogs in the households, 1242 dogs (28.7%) were eligible for oral vaccine. 659 (53%) were considered to have accepted the oral vaccine with release of the vaccine in the oral cavity. CONCLUSION: It is feasible to use oral rabies vaccine to enhance immunisation coverage.
OBJECTIVE: To test the feasibility of introducing oral rabies vaccine (vaccinia recombinant rabies glycoprotein) to improve domestic dog immunisation coverage in a selected area. DESIGN: A prospective field trial. SETTING: Panadura, an area relatively isolated by waterways, making it a suitable field laboratory. METHODS: A routine parenteral vaccination program was carried out. A house to house survey identified the residual non-vaccinated dogs in the selected area. Oral vaccine was offered to the non-vaccinated domestic dogs. RESULTS: Of 4322 dogs in the households, 1242 dogs (28.7%) were eligible for oral vaccine. 659 (53%) were considered to have accepted the oral vaccine with release of the vaccine in the oral cavity. CONCLUSION: It is feasible to use oral rabies vaccine to enhance immunisation coverage.
Authors: Gino C Matibag; Taro Kamigaki; Pallegoda V R Kumarasiri; Thula G Wijewardana; Anil W Kalupahana; D R Anuruddhika Dissanayake; D D Niranjala De Silva; G S Panduka De S Gunawardena; Yoshihide Obayashi; Koji Kanda; Hiko Tamashiro Journal: Environ Health Prev Med Date: 2007-03 Impact factor: 3.674
Authors: Florence Cliquet; Anne-Laure Guiot; Michel Aubert; Emmanuelle Robardet; Charles E Rupprecht; François-Xavier Meslin Journal: Vet Res Date: 2018-07-13 Impact factor: 3.683